Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21115882 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses
Condition: Precancerous Condition
Interventions: Drug: celecoxib;   Drug: Placebo

Indicates status has not been verified in more than two years